Anti-Human TGFB1 Recombinant Antibody
-
产品编号
YR1121
-
别名
科研级 Metelimumab ( 美替木单抗 ), Anti-TGFB1 Recombinant Antibody, Research Grade Metelimumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Metelimumab ( 美替木单抗 ), Anti-TGFB1 Recombinant Antibody, Research Grade Metelimumab |
Catalog Number | YR1121 |
Molecular Name | Metelimumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG4 Kappa |
Formulation | PBS, pH7.5 |
Background | Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which had been chosen for further development for the treatment of diffuse cutaneous systemic sclerosis, also known as scleroderma. It was dropped from further development in favour of fresolimumab, which was being developed by Genzyme as of 2006. |
CAS Number | 272780-74-2 |
Application | IF, IP, Neut, FuncS, ELISA, FCM, ICC |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | TGFB1[Homo sapiens] |